Article

EDUCATED PATIENT Lung Cancer Webinar: Eastern Region

Author(s):

CURE hosted its second webinar that will focus on all the latest topics and trends for patients with lung cancer.

Lung cancer is the most common form of cancer in the United States and is the deadliest. However, the lung cancer landscape is evolving to meet the demands of the disease and find new ways to detect, prevent and treat lung cancer.

On Monday, June 8th, CURE® gathered top experts in the field of lung cancer for an informative lung cancer webinar focused on topics that were highly relevant to patients, caregivers and advocates, including current trends with lung cancer diagnoses, COVID-19 symptom overlap and minimizing risk, biomarker testing and more.

PRESENTING FACULTY include:

Stephen Liu, MD

Associate Professor of Medicine

Director, Thoracic Oncology

Director, Developmental Therapeutics

Georgetown University

Lombardi Comprehensive Cancer Center

Charu Aggarwal, MD

Leslye M. Heisler Assistant Professor for Lung Cancer Excellence

Abramson Cancer Center

University of Pennsylvania

Upal Basu Roy, PhD, MPH

Vice President of Research

LUNGevity Foundation

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.